Sanofi at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
Sanofi takes part in 8 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions cover mRNA vaccine platforms, pandemic preparedness and how to design and run vaccine trials faster. The most unusual topic is a vaccine being developed to treat acne, alongside an H5 pandemic flu mRNA program and vaccine safety monitoring in the AI era.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
Sanofi Paris, France | |
Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs. | Talk Mon Oct 19 11:30 Talk Mon Oct 19 14:45 Talk Mon Oct 19 15:30 Talk Tue Oct 20 09:00 The Technology Revolution: Agility for the Wave of Next Generation Vaccines Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease. Platforms & delivery Talk Wed Oct 21 12:45 Panel: From Bottleneck to Breakthrough: Reengineering Vaccine Clinical Development Why vaccine development has slowed back to pre-pandemic speeds and which changes, including AI, could make clinical trials faster. Talk Wed Oct 21 13:30 Talk Wed Oct 21 15:00 Panel: Designing Better Vaccine Trials: The Role and Reality of Modelling Whether models built from manufacturing and early trial data can shrink vaccine trials, and what evidence regulators need to trust them. |
Instantly find 20 buyers from Sanofi
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction